Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomarin Pharmaceutical

56.65
+1.382.50%
Post-market: 56.890.2400+0.42%19:35 EDT
Volume:2.13M
Turnover:120.39M
Market Cap:10.86B
PE:20.94
High:57.81
Open:55.64
Low:55.64
Close:55.27
Loading ...
Aug 28, 2024

Major Issues Report

Form 8-K - Current report
Aug 22, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2024

Major Issues Report

Form 8-K - Current report
Jul 10, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 24, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 26, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]